Skip to main content
. 2000 Mar;49(3):254–263. doi: 10.1046/j.1365-2125.2000.00166.x

Table 4.

Identification of individual drug entities included within drug groups in Dutch HDFs (n = 62). The musculoskeletal and central nervous system.

HDFs HDFs
Drug group (ATC code) Year* n (%) Drug group(ATC code) Year* n (%)
NSAIDs(M01A/N02BB/N02BG) Benzodiazepines(N05BA/N05 CD) None 1 (2)
Acetic acid derivates Alprazolam *** 1983 0 (0)
Aceclofenac 1997 0 (0) Bromazepam 1974 0 (0)
Diclofenac ** 1974 60 (97) Brotizolam 1982 2 (3)
Indomethacin 1963 56 (90) Chlorodiazepoxide *** 1960 0 (0)
Sulindac 1976 11 (18) Clobazam *** 1975 0 (0)
Tolmetine 1975 2 (3) Clorazepinic acid *** 1967 0 (0)
Diazepam **/+ 1961 23 (37)
Oxicam derivates Flunitrazepam *** 1974 11 (18)
Meloxicam 1996 1 (2) Flurazepam *** 1968 19 (31)
Piroxicam 1979 27 (44) Ketazolam 1980 0 (0)
Tenoxicam *** 1986 0 (0) Loprazolam 1983 0 (0)
Loprazolam 1971 17 (28)
Proprionic acid derivates Lormetazepam 1980 25 (40)
Fenoprofen 1974 0 (0) Medazepam *** 1968 27 (44)
Flurbiprofen 1977 0 (0) Midazolam 1982 0 (0)
Ibuprofen **/+ 1969 59 (95) Nitrazepam ** 1965 47 (76)
Ketoprofen 1973 19 (31) Nordazepam *** 1975 0 (0)
Naproxen ** 1973 57 (92) Oxazepam 1964 19 (31)
Tiaprofenic acid 1980 0 (0) Prazepam *** 1973 0 (0)
Temazepam ** 1969 61 (98)
Pyrazolinon derivates Triazolam 1978 0 (0)
Aminophenazone 1887 0 (0) Zolpidem 1988 4 (7)
Phenazone 1884 0 (0) Zopiclon 1985 12 (19)
Metamizol *** 1946 3 (5)
Propyphenazone 1951 0 (0)
Other
Azapropazone 1970 9 (14)
Floctafenine 1976 0 (0)
Ketorolac 1990 0 (0)
Phenylbutazone 1949 13 (21)
Nabumeton 1985 7 (11)
Proquazone 1977 0 (0)
Tolphenaminic acid 1975 0 (0)
*

Year of introduction to the pharmaceutical market

**

Recommended by national guidelines

***

Not preferred or insufficiently evaluated by guideline authorities; Drug entities without asterisks are not considered in the national pharmacotherapeutic guidelines

+

Included in the 10th edition of the WHO EDL.